Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06719180Phase 4Recruiting
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by MediSys Health Network. Primary endpoint: Milligrams of Morphine Equivalent Used at 4 hours. Started Dec 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06719180.